Rare mutations are helping dangerous hospital bacteria slip past the last-line antibiotic

Rare mutations are helping dangerous hospital bacteria slip past the last-line antibiotic defense. Another last-resort antibiotic has fallen victim to the rapid evolution of drug-resistant superbugs.

A apuração publicada por phys.org vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Another last-resort antibiotic has fallen victim to the rapid evolution of drug-resistant superbugs. The powerful antibiotic combination ceftazidime-avibactam (CZA), widely used to treat severe hospital-acquired infections caused by Pseudomonas aeruginosa—particularly in critically ill and immunocompromised patients—can no longer eliminate some of these infections.

• Ponto de atenção: rare.
• Ponto de atenção: mutations.
• Ponto de atenção: helping.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Agro. Quando fizer sentido, a referência complementar pode ser acessada em produtos do campo.